Searchable abstracts of presentations at key conferences in endocrinology

ea0070ep558 | Hot topics (including COVID-19) | ECE2020

SGLT-2 inhibitors as adjunctive therapy in type 1 diabetes: Short experience from a center

Salazar Daniela , Esteves César , Carvalho Davide

Background: Sodium-glucose cotransporter-2 (SGLT-2) inhibitors were recently approved as adjunctive treatment for type 1 diabetes (T1D), contributing to better glycemic control, cardiovascular and renal protection. Aim: access the efficacy and safety of these antidiabetic agents in selected T1D patients.Methods: Evaluation of medical records of T1D patients starting SGLT-2 inhibitors between August 2018 and October 2019.Results: 24...

ea0032p139 | Calcium and Vitamin D metabolism | ECE2013

Familiar hypocalciuric hypercalcemia a rare cause of hypercalcemia

Belo Sandra , Magalhaes Angela , Capela Joao , Carvalho Davide

Introduction: Familial hypocalciuric hypercalcemia (FHH) is caused by inactivating autosomal dominant mutations with high penetrance of CaSP gene. Contrary to severe neonatal hyperparathyroidism, caused by homozygous inactivation of the gene, familial hypocalciuric hypercalcemia is usually associated with inactivating variants in heterozygoty.Case: Male patient, 73 years, with history of Behçet’s disease and pulmonary sarcoidosis, was refered f...

ea0032p632 | Growth hormome IGF axis – basic | ECE2013

Glucose metabolism abnormalities in a population of acromegalic patients

Nogueira Claudia , Belo Sandra , Vinha Eduardo , Magalhaes Angela , Carvalho Davide

Introduction: There is a well-established association between acromegaly and insulin resistance (IR). The abnormalities in glucose metabolism may be an important risk factor of cardiovascular morbid-mortality in these patients.Objective: Evaluation of glucose metabolism abnormalities in a population of naïve acromegalic patients and its relationship with delay in diagnosis, gender, levels of insulin like growth factor 1 (IGF1) and GH.<p class="a...

ea0032p894 | Pituitary – Clinical (<emphasis role="italic">Generously supported by IPSEN</emphasis>) | ECE2013

Familiar panhypopituitarism by a mutation in PROP1: four of seven brothers affected

Lau Eva , Freitas Paula , Coutinho Eduarda , Lemos Manuel , Carvalho Davide

Introduction: Generously supported by IPSEN)-->PROP1 (Prophet of Pit-1) mutations are the most frequent genetic cause of panhypopituitarism, a condition associated with a deficiency or inadequate production of hormones of the anterior pituitary. The PROP1 gene encodes a transcription factor involved in the ontogeny, differentiation and function of somatotrophs, lactotrophs and thyrotrophs. These mutations are characterized by a remar...

ea0032p1067 | Thyroid (non-cancer) | ECE2013

Marine–lenhart syndrome

Esteves Cesar , Neves Celestino , Vieira Tiago , Pereira Jorge , Carvalho Davide

Introduction: The Marine–Lenhart syndrome is a rare cause of hyperthyroidism that is associated with the simultaneous or sequential presence of characteristics related to Graves’ disease and toxic nodular or multinodular goiter. It’s validity as a disease is controversial and some authors believe that these are cases of hyperthyroidism where both etiologies coexist. The presence of hyperfunctioning nodules in Graves’ disease patients ranges between 0.8 and ...

ea0081p538 | Adrenal and Cardiovascular Endocrinology | ECE2022

Primary adrenal angiosarcoma within a hematoma

Rodrigues Elisabete , Oimenta Tiago , Pinheiro Jorge , Carvalho Davide , Manuel Lopes Jose

Introduction: Angiosarcomas account for < 1% of all sarcomas, and are highly agressive neoplasms whose clinical course is striking: local recurrence, metastasis, and a high mortality rate. Primary angiosarcoma of the adrenal gland was first described in 1988 by Kareti et al. and is very rare with, so far, only 51 reported cases. Case report: A 49-year-old male, without prior malignancy, presented with a 4.9x5.9 cm right adrenal nodule and a 2.4 cm le...

ea0081p469 | Thyroid | ECE2022

Graves’ disease and polymorphisms in proinflammatory cytokines genes

Neves Celestino , Neves Joao Sergio , Goncalves Juliana , Soares Paula , Luis Medina Jose , Carvalho Davide

Background: Graves’ Disease (GD) is one of the most common organ specific autoimmune disorders, being characterized by an abnormal production of stimulating autoantibodies to the thyrotropin receptor (TSHR). Some studies demonstrated that genetic polymorphisms in certain cytokines, namely interleukin-6 (IL-6), tumor necrosis factor-α (TNF-α), interleukin-1β (IL-1β), are associated with a greater susceptibility of developing GD. Our aim was to evaluate ...

ea0081p488 | Thyroid | ECE2022

Autoimmune thyroiditis, quality of life and underlying symptomatology

Pereira Miguel , Neves Celestino , Neves Joao Sergio , Goncalves Juliana , Carvalho Davide

Introduction: Hypothyroidism caused by autoimmune thyroiditis (AIT) is a disease that can originate physical, psychological and behavioral symptoms. Quality of life (QoL) and psychopathologial symptoms in thyroid diseases and its relation with thyroid function remains unclear. In hypothyroidism there is a discussion about the normal range of TSH and Free T4 values and in which way its fluctuation influences the patient in its daily activities.Objective: ...

ea0081ep1007 | Thyroid | ECE2022

Quality of life and symptomatology in patients with hypothyroidism post-graves’ disease

Pereira Miguel , Neves Celestino , Goncalves Juliana , Neves Joao Se rgio , Carvalho Davide

Introduction: Quality of life (QoL) and its related physical and psychological symptomatology is an important factor when we treat Graves’ disease.Objective: To analyze the QoL and physical and psychological symptomatology of patients with hypothyroidism after definitive treatment of Graves’ disease.Methods: We evaluated 16 patients with hypothyroidism that previously had Graves’ disease. These patients were submitte...

ea0084ps2-07-60 | Graves’ Disease 1 | ETA2022

Polymorphisms in proinflammatory cytokines’ genes and lipid profile in patients with graves’ disease

Neves Celestino , Sergio Neves Joao , Goncalves Juliana , Soares Paula , Delgado Luis , Carvalho Davide

Objective: Graves’ Disease (GD) is one of the most common autoimmune disorders. Some SNP in pro-inflammatory cytokines have already been linked to an increased susceptibility of developing GD. Thyroid hormones are crucial modulators of lipid metabolism. A pro-inflammatory state, may contribute several metabolic changes, including disturbances in lipid metabolism. Our aim was to evaluate if SNP in pro-inflammatory cytokines also contribute to disturbances of lipid profile ...